Graphene‐Based Nanomaterials as Bioactive Agents and Drug Delivery Systems for Bone Tissue Engineering
Journal of Biomedical Materials Research Part A · 2026
DOI: 10.1002/jbm.a.70129 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biomedical Materials Research Part A, 2026. Verfasst von Sijian Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases and National Center for Stomatology and National Clinical Research Center for Oral Diseases, West China Hospita…. Hauptthemen laut MEDLINE: Tissue Engineering, Graphite, Drug Delivery Systems, Bone and Bones. Die Arbeit nennt 210 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Graphene‐based nanomaterials (GBNs), such as graphene oxide and reduced graphene oxide, have been considered as promising functional materials for bone tissue engineering due largely to their intrinsic biological functions and great drug delivery capacity. As bioactive materials, GBNs possess antibacterial activity, photothermal effect, and the ability to regulate immune microenvironment and osteogenesis‐related signaling pathways such as Wnt/β‐catenin, MAPK, and BMP/Smad. As drug delivery systems, the large surface area and multiple functionalization sites allow GBNs to have great potential in loading and delivering various active agents, such as drugs, genes, and growth factors. Based on these properties, GBNs prevent infections, facilitate stem cell adhesion, proliferation, and osteogenic differentiation, and ultimately promote bone regeneration. In the past few years, reports regarding the applications of GBNs in bone tissue engineering have been well documented, but the clinical translation is still limited. Herein, on the basis of the two major roles of GBNs (bioactive agents and drug delivery systems), we aim to provide a comprehensive understanding of the multiple functions and mechanisms of GBNs in promoting bone tissue regeneration. The progress and challenges in clinical translation are also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases and National Center for Stomatology and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
ORCID-Profile: Qiang Peng
Förderung
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Yu, S., Liu, J., Zhou, X., & Peng, Q. (2026). Graphene‐Based Nanomaterials as Bioactive Agents and Drug Delivery Systems for Bone Tissue Engineering. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.70129
Vancouver
Yu S, Liu J, Zhou X, Peng Q. Graphene‐Based Nanomaterials as Bioactive Agents and Drug Delivery Systems for Bone Tissue Engineering. Journal of Biomedical Materials Research Part A. 2026. doi:10.1002/jbm.a.70129
BibTeX
@article{Yu2026,
author = {Yu, Sijian and Liu, Jianhong and Zhou, Xueer and Peng, Qiang},
title = {Graphene‐Based Nanomaterials as Bioactive Agents and Drug Delivery Systems for Bone Tissue Engineering},
journal = {Journal of Biomedical Materials Research Part A},
year = {2026},
doi = {10.1002/jbm.a.70129}
}
EUVIMED